GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Cardica, Inc. (CRDC) [hlAlert]

Rating:
Hold CRDC
down 49.52 %

Cardica, Inc. (CRDC) downgraded to Hold by Brean Murray

Posted on: Friday,  Aug 14, 2009  8:25 AM ET by Brean Murray

Brean Murray rated Hold Cardica, Inc. (NASDAQ: CRDC) on 08/14/2009. Previously Brean Murray rated Buy Cardica, Inc. (NASDAQ: CRDC) on 01/30/2009.,
when the stock price was $3.15. Since then, Cardica, Inc. has lost 49.52% as of 08/14/2009's recent price of $1.59.
If you would have followed the previous Brean Murray's recommendation on CRDC, you would have lost 49.52% of your investment in 196 days.

Cardica, Inc. designs and manufactures proprietary automated anastomotic systems used by surgeons to perform coronary artery bypass graft surgery. In these surgery procedures, veins or arteries are used to construct alternative conduits to restore blood flow beyond narrowed or occluded portions of coronary arteries, bypassing the narrowed or occluded portion of the artery that is impairing blood flow to the heart muscle. Our first two products, the C-Port Distal Anastomosis System, and the PAS-Port Proximal Anastomosis System, provide cardiovascular surgeons with easy-to-use automated systems to perform consistent, rapid and reliable connections, or anastomoses, of the vessels, which surgeons generally view as the most critical aspect of the bypass procedure.

Our equity research department is focused on fundamental analysis across the universe of over 200 small/mid cap stocks in our five target sectors. We are committed to providing proprietary action-oriented research to our institutional clients. Small cap growth focus. Our primary area of concentration is growth stocks with market capitalization of $200 million to $5 billion. Global perspective. We are covering U.S. listed stocks for companies domiciled in the U.S., China, Europe and Latin America, with our biggest concentration in the US and China. We were one of the first banks to aggressively expand our research to China and we believe we created one of the premier research franchises in small cap, U.S. listed Chinese companies to complement our strong domestic coverage. Disciplined stock selection. Our research analysts are focused on performing extensive bottoms up due diligence on companies under our coverage by leveraging their industry and management contacts. By combining our bottoms up work with our sector views we seek to generate a consistent flow of high conviction ideas for our clients. Diversified coverage. Our areas of expertise include technology, consumer, healthcare, resources and China small cap. We provide our clients with company-specific as well as sector-specific research across our target sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/14/2009 8:25 AM Hold
None
1.59
as of 12/31/2009
1 Week   
1 Month   
3 Months   
1 YTD down  -54.57 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/30/2009 12:25 PM Buy
None
3.15 6.00
10/16/2008 8:25 AM Buy
None
5.72 9.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy